The decision should be made collaboratively between patient and clinician, considering efficacy, safety, administration route, cost, and individual treatment goals, in line with NICE NG28 guidance
Animal studies show semaglutide is excreted in breast milk, and human data is absent
COA verification, batch testing, and storage handling are buyer-side responsibilities
And there are more questions employers may be exploring with respect to covering GLP-1s for weight loss, such as: What about coverage for diabetics who are taking the medication already
As with all injectable peptide-based therapies, proper patient monitoring and clinical oversight are required
This specialization means your treatment plan accounts for factors like testosterone levels that a general provider might overlook